Disclosure under regulation 29(2) of SEBI (SAST) Regulations, 2011 received from Ishita Pharmaceuticals, related party of Ishita Drugs and Industries Limited.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ishita Pharmaceuticals, a related party of Ishita Drugs & Industries Ltd, acquired 946 equity shares (face value Rs. 10 each) through the open market on February 19, 2026. This was a very small purchase, taking the related party's holding from 30,800 shares (1.03%) to 31,746 shares (1.06%) of the company. The total equity share capital of Ishita Drugs stands at Rs. 2.99 crore (29,90,300 shares of Rs. 10 each). The disclosure was filed under SEBI's substantial acquisition and takeovers regulations.
This is a tiny, routine acquisition by a related party with negligible impact on ownership structure or stock price. The stake increase is just 0.03 percentage points and not material to investors.